25Mar 2023
Comparative evaluation of PD‐L1 expression in cytology imprints, circulating tumour cells and tumour tissue in non‐small cell lung cancer patients

Comparative evaluation of PD‐L1 expression in cytology imprints, circulating tumour cells and tumour tissue in non‐small cell lung cancer patients

The study evaluated the use of liquid biopsies and cytology imprints as alternatives to immunohistochemistry for assessing PD-L1 expression in patients with non-small cell lung cancer (NSCLC). The results showed comparable PD-L1 expression between the different approaches, indicating that cytology imprints and liquid biopsies could be complementary to conventional immunohistochemistry for assessing PD-L1 expression. Cytology imprints and CTCs were also found to be useful for predicting PD-L1 positivity in cases where no tumor tissue is available.

  • #oncology

Like

Save

Share